Relevance of DNA-ploidy as a prognostic instrument for solid tumors

This publication has 25 references indexed in Scilit:

• Flow cytometric DNA ploidy defines patients with poor prognosis in node-negative breast cancer
  International Journal of Cancer, 2007
• Correlation between p53, c-erbB-2, and topoisomerase II? expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negative breast carcinomas: prognostic implications
  The Journal of Pathology, 1999
• Enzyme-linked immunoabsorbent assay-detected p53 protein accumulation: a prognostic factor in a large breast cancer cohort.
  Journal of Clinical Oncology, 1998
• P53 expression, DNA ploidy and S-phase cell fraction in operable locally advanced non-small-cell lung cancer
  British Journal of Cancer, 1996
• The prognostic significance of DNA flow cytometry in breast cancer: results from 881 patients treated in a single centre
  British Journal of Cancer, 1995
• Biological Markers for Designing Clinical Protocols
  Annals of the New York Academy of Sciences, 1993
• Prognostic significance of proliferative activity and ploidy in node-negative breast cancers
  Annals of Oncology, 1993
• Breast Cancer Prognostic Factors: Evaluation Guidelines
  JNCI Journal of the National Cancer Institute, 1991
• Prediction of Relapse or Survival in Patients with Node-Negative Breast Cancer by DNA Flow Cytometry
  New England Journal of Medicine, 1989
• PLOIDY AS A PROGNOSTIC DETERMINANT IN SURGICALLY TREATED LUNG CANCER
  The Lancet, 1987